Overview of Lower Respiratory Tract Infections: Diagnosis and Treatment

REFERENCES

1. ↵
   1. Murphy S. L.

   (2000) Deaths: final data for 1998. Natl Vital Stat Rep 48:1–105, pmid:10934859.

   OpenUrlPubMed
2. ↵
   1. Bartlett J. G.,
   2. Dowell S. F.,
   3. Mandell L. A.

   (2000) Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 31:347–382, pmid:10987697.

   OpenUrlCrossRefPubMed
3. ↵
   1. Gay K.,
   2. Baughman W.,
   3. Miller Y.

   (2000) The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment. J Infect Dis 182:1417–1424, pmid:11023465.

   OpenUrlCrossRefPubMedWeb of Science
4. 1. Jacobs M. R.,
   2. Bajaksouzian S.,
   3. Zilles A.

   (1999) Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study. Antimicrob Agents Chemother 43:1901–1908, pmid:10428910.

   OpenUrlAbstract/FREE Full Text
5. 1. Thornsberry C.,
   2. Ogilvie P.,
   3. Kahn J.

   (1997) Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory season. The Laboratory Investigator Group. Diagn Microbiol Infect Dis 29:249–257, pmid:9458982.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   (1993) Guidelines for the management of community-acquired pneumonia in adults admitted to the hospital. The British Thoracic Society. Br J Hosp Med 49:346–350, pmid:8472086.

   OpenUrlPubMedWeb of Science
7. 1. Mandell L. A.,
   2. Marrie T.,
   3. Yu V.

   (1994) Antimicrobial treatment of community-acquired pneumonia in adults: a conference report. Can J Infect Dis 5((Suppl C)):56C–59C.

   OpenUrl
8. ↵
   1. Niederman M. S.,
   2. Bass J. B. Jr.,
   3. Campbell G. D.

   (1993) Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis 148:1418–1426, pmid:8239186.

   OpenUrlCrossRefPubMed
9. ↵
   1. Bartlett J. G.,
   2. Breiman R. F.,
   3. Mandell L. A.

   (1998) Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America. Clin Infect Dis 26:811–838, pmid:9564457.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    1. Heffelfinger J. D.,
    2. Dowell S. F.,
    3. Jorgensen J. H.

    (2000) Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med 160:1399–1408, pmid:10826451.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Mandell L. A.,
    2. Marrie T. J.,
    3. Grossman R. F.

    (2000) Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis 31:383–421, pmid:10987698.

    OpenUrlCrossRefPubMed
12. ↵
    1. Niederman M. S.,
    2. Mandell L. A.,
    3. Anzueto A.

    (2001) Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163:1730–1754, pmid:11401897.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    1. Fine M. J.,
    2. Auble T. E.,
    3. Yealy D. M.

    (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243–250, pmid:8995086.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    1. Hyde T. B.,
    2. Gay K.,
    3. Stephens D. S.

    (2001) Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA 286:1857–1862, pmid:11597287.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    1. Kelley M. A.,
    2. Weber D. J.,
    3. Gilligan P.

    (2000) Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. Clin Infect Dis 31:1008–1011, pmid:11049784.

    OpenUrlCrossRefPubMedWeb of Science